TRPC3 (and TRPC6) are receptor-activated, non-selective cation channels belonging to the canonical transient receptor potential (TRPC) channel family. They are activated by diacylglycerol (DAG), a lipid second messenger (Hofmann T et al. 1999). TRPC3 is involved in many physiological processes and implicated in human genetic diseases. The high-affinity inhibitor BTDM wedges between the S5-S6 pore domain and the voltage sensor-like domain to inhibit channel opening (Tang Q et al. 2018).
Activation of these channels leads to cell membrane depolarization and calcium influx. TRPC3/6/7 can form either homotetramers or heterotetramers with variable calcium ion permeability. Based on their sequence features, these channels have a tetrameric transmembrane pore that consists of six transmembrane helices, just as in other TRP channels. In addition, they have a large cytoplasmic N-terminus that contains four ankyrin repeats and a C-terminal coiled-coil motif. How these structural elements are incorporated into the tetrameric TRPC channel is largely unknown (Tang Q et al. 2018). In skin, TRPC channels (TRPC1, TRPC3, TRPC4, TRPC5, and TRPC6) are expressed by keratinocytes, where they appear to be involved in the differentiation and proliferation of these cells. Furthermore, TRPC1 and TRPC3 are also expressed in CD4+ T cells, and in neurons of various ganglia. Ganglia.
TRPC3 is also highly expressed in human hypertrophic scar tissue, and mechanical stimuli are known to upregulate TRPC3 expression in human skin fibroblasts in vitro. Animal experiments have shown that mechanical stretching controls fibronectin expression via the TRPC3-NFkB axis, resulting in persistent wound contracture. This model explains how mechanical stretching of skin wounds can lead to pathological scars (Ishise H et al. 2015). Whether TRPC2 plays a role in melanoma cell invasion is currently unclear (Gao J et al. 2018).